Assignee
SHAPE THERAPEUTICS INC
US·2 granted patents·30 pending applications·4 citations·filing 2020–2025
Top patents by PatentIndex Score
32 records- 0185US12054738B2Stable cell lines for inducible production of rAAV virionsSHAPE THERAPEUTICS INC·Filed 2021·Granted Aug 6, 2024·3 cites·32 claims
- 0277US11827880B2Therapeutic editingSHAPE THERAPEUTICS INC·Filed 2020·Granted Nov 28, 2023·1 cites·34 claims
- 0368US2025146020A1Stable Cell Lines for Inducible Production of rAAV VirionsSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0467US2024279650A1Therapeutic EditingSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0562US2026002177A1High throughput engineering of functional aav capsidsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0660US2023048732A1High throughput engineering of functional aav capsidsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0760US2024360473A1Compositions and Methods for AAV ProductionSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0860US2025022532A1Regulating enhancer activity using machine-learningSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0959US2025066774A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1059US2025009904A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1158US2025342903A1Methods and systems for transformer-based biological sequence modelsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1258US2025026795A1Functional aav capsids for intravitreal administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2025059538A1COMPOSITIONS AND METHODS OF tRNA SILENCINGSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1457US2025205363A1Functional aav capsids for systemic administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2025129127A1Systems for Amplification of AAV Rep and Cap ProteinsSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1655US2025356949A1Machine-learning based design of engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1754US2025084408A1Engineered rnasSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1853US2025109410A1Stable Cell Lines for Inducible Production of rAAV VirionsSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1952US2024271139A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2052US2024279656A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2151US2024124850A1Auxotrophic Cells for Virus Production and Compositions and Methods of MakingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2250US2024011028A9Compositions and Methods Using SNRNA ComponentsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2350US2023399635A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2449US2023183689A1Compositions and Methods for Genome EditingSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2549US2026069718A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2649US2024102083A1High throughput rna-editing screening methodsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2749US2025222139A1Promoter switches for tissue-specific expressionSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2848US2024238447A1Compositions and methods for modulating payload expression at a transcriptional levelSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2948US2023174977A1Engineered circular polynucleotidesSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3046US2025014676A1Generative sequence screening with conditional gans, diffusion models, and denoising diffusion conditional gansSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3141US2023242910A1Methods and compositions relating to engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3237US2023174976A1Targeted rna editing using engineered adenosine deaminase acting on trna (adat) systemsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHAPE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →